Moxifloxacin (hydrochloride monohydrate)

Moxifloxacin (BAY 12-8039) hydrochloride monohydrate is an orally active bacterial inhibitor that is effective against Streptococcus pneumoniae. Moxifloxacin hydrochloride monohydrate can be used in tuberculosis research[1][2].

Product Specifications

CAS Number

[192927-63-2]

Product Name Alternative

BAY 12-8039 (monohydrate)

UNSPSC

12352200

Hazard Statement

H341

Target

Antibiotic; Bacterial

Type

Biochemical Assay Reagents

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/moxifloxacin-hydrochloride-monohydrate.html

Purity

99.87

Solubility

10 mM in DMSO

Smiles

O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC)C1=O)O.Cl.O

Molecular Formula

C21H27ClFN3O5

Molecular Weight

455.91

Precautions

H341

References & Citations

[1]Pestova E, et al. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother. 2000 May;45 (5) :583-90.|[2]Miyazaki E, et al. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother. 1999 Jan;43 (1) :85-9.